A phase II study of carboplatin in advanced or metastatic stomach cancer.
Beer
M
M
Servizio Oncologico, Ospedale S. Giovanni, Bellinzona, Switzerland.
Cavalli
F
F
Kaye
S B
SB
Lev
L M
LM
Clavel
M
M
Smyth
J
J
van Glabbeke
M
M
Renard
J
J
Pinedo
H M
HM
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D016190:Carboplatin